Advertisement
Advertisement
Trending on Urology Times
1
Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC
2
First commercial procedures performed with Zenflow Spring for BPH
3
Dabogratinib shows early activity in FGFR3-altered LG-IR-NMIBC
4
The critical role of advocacy in urologic oncology
5
